Lantheus Holdings (LNTH) Change in Cash (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Change in Cash of $139.5 million for Q1 2026, up 442.09% year-over-year from $25.7 million in Q1 2025, and up 709.62% quarter-over-quarter from -$22.9 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Cash (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Change in Cash for 13 consecutive years, with $139.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 442.09% year-over-year to $139.5 million; the TTM figure through Mar 2026 stood at -$439.9 million (down 299.7% YoY), while the FY2025 annual figure was -$553.7 million, down 377.94% from the prior year.
- Change in Cash improved to $139.5 million in Q1 2026 per LNTH's latest filing, from -$22.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $200.1 million in Q3 2023 and bottomed at -$313.6 million in Q3 2025.
- Historically, Change in Cash has averaged $23.5 million across 5 years, with a median of $46.4 million in 2024.
- Annual changes were most pronounced in 2022 — Change in Cash jumped 341188.0% — and 2025, when it slumped 726.97%.
- Lantheus Holdings' Change in Cash stood at $158.4 million in 2022, then sank by 37.16% to $99.5 million in 2023, then tumbled by 53.35% to $46.4 million in 2024, then sank by 149.27% to -$22.9 million in 2025, then jumped by 709.62% to $139.5 million in 2026.
- Business Quant data shows LNTH's Change in Cash at $139.5 million in Q1 2026, -$22.9 million in Q4 2025, and -$313.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 94.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94.72 Mn |
| Mar 31, 2026 | 139.47 Mn |
| Dec 31, 2025 | -22.88 Mn |
| Sep 30, 2025 | -313.56 Mn |
| Jun 30, 2025 | -242.95 Mn |
| Mar 31, 2025 | 25.73 Mn |
| Dec 31, 2024 | 46.44 Mn |
| Sep 30, 2024 | 109.38 Mn |
| Jun 30, 2024 | 38.75 Mn |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | 99.54 Mn |
| Sep 30, 2023 | 200.07 Mn |
| Jun 30, 2023 | -56.78 Mn |
| Mar 31, 2023 | 55.22 Mn |
| Dec 31, 2022 | 158.40 Mn |
| Sep 30, 2022 | 85.27 Mn |
| Jun 30, 2022 | 66.07 Mn |
| Mar 31, 2022 | 6.85 Mn |
| Dec 31, 2021 | 7.03 Mn |
| Sep 30, 2021 | -25,000.00 |